Interestingly, the Danish Head Neck Cancer Study Group randomised trial showed that mild acceleration of radiotherapy was more effective in well-differentiated HNSCC cases, expected to have a higher percentage of CD44+ cells according to our study (Eriksen et al, 2005). The gene discussed is CD44; the disease is head and neck cancer.